...
首页> 外文期刊>Clinical Orthopaedics and Related Research >Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds?
【24h】

Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds?

机译:炎症标记物是否预示着战斗伤口中的异位骨化和伤口衰竭?

获取原文
获取原文并翻译 | 示例

摘要

Background: After a decade of war in Iraq and Afghanistan, we have observed an increase in combat-related injury survival and a paradoxical increase in injury severity, mainly because of the effects of blasts. These severe injuries have a devastating effect on each patient's immune system resulting in massive upregulation of the systemic inflammatory response. By examining inflammatory mediators, preliminary data suggest that it may be possible to correlate complications such as wound failure and heterotopic ossification (HO) with distinct systemic and local inflammatory profiles, but this is a relatively new topic. Questions/purposes: We asked whether systemic or local markers of inflammation could be used as an objective means, independent of demographic and subjective factors, to estimate the likelihood of (1) HO and/or (2) wound failure (defined as wounds requiring surgical débridement after definitive closure, or wounds that were not closed or covered within 21 days of injury) in patients sustaining combat wounds. Methods: Two hundred combat wounded active-duty service members who sustained high-energy extremity injuries were prospectively enrolled between 2008 and 2012. Of these 200 patients, 189 had adequate followups to determine the presence or absence of HO, and 191 had adequate followups to determine the presence or absence of wound failure. In addition to injury-specific and demographic data, we quantified 24 cytokines and chemokines during each débridement. Patients were followed clinically for 6 weeks, and radiographs were obtained 3 months after definitive wound closure. Associations were investigated between these markers and wound failure or HO, while controlling for known confounders. Results: The presence of an amputation (p < 0.001; odds ratio [OR], 6.1; 95% CI. 1.63-27.2), Injury Severity Score (p = 0.002; OR, 33.2; 95% CI, 4.2-413), wound surface area (p = 0.001; OR, 1.01; 95% CI, 1.002-1.009), serum interleukin (IL)-3 (p = 0.002; OR, 2.41; 95% CI, 1.5-4.5), serum IL-12p70 (p = 0.01; OR, 0.49; 95% CI, 0.27-0.81), effluent IL-3 (p = 0.02; OR, 1.75; 95% CI, 1.2-2.9), and effluent IL-13 (p = 0.006; OR, 0.67; 95% CI, 0.50-0.87) were independently associated with HO formation. Injury Severity Score (p = 0.05; OR, 18; 95% CI, 5.1-87), wound surface area (p = 0.05; OR, 28.7; 95% CI, 1.5-1250), serum procalcitonin ([ProCT] (p = 0.03; OR, 1596; 95% CI, 5.1-1,758,613) and effluent IL-6 (p = 0.02; OR, 83; 95% CI, 2.5-5820) were independently associated with wound failure. Conclusions: We identified associations between patients' systemic and local inflammatory responses and wound-specific complications such as HO and wound failure. However, future efforts to model these data must account for their complex, time dependent, and nonlinear nature. Level of Evidence: Level II, prognostic study. See the Instructions for Authors for a complete description of levels of evidence.
机译:背景:在伊拉克和阿富汗战争十年后,我们观察到与战斗有关的伤害幸存时间增加,伤害严重程度却出现了矛盾的增加,这主要是由于爆炸的影响。这些严重伤害对每个患者的免疫系统都具有毁灭性影响,导致全身性炎症反应大量上调。通过检查炎症介质,初步数据表明可能将诸如伤口衰竭和异位骨化(HO)等并发症与独特的全身和局部炎症相联系,但这是一个相对较新的话题。问题/目的:我们询问是否可以使用炎症的全身或局部标志物作为独立于人口统计学和主观因素的客观手段,以评估(1)HO和/或(2)伤口衰竭(定义为伤口需要保留战斗伤口的患者在最终闭合后进行手术清创术,或在受伤后21天内未闭合或覆盖的伤口。方法:2008年至2012年期间共招募了200名遭受高能肢体损伤的作战伤员,其中200名患者中有189例接受了充分的随访以确定是否存在HO,有191例进行了随访。确定是否存在伤口衰竭。除了特定损伤和人口统计数据外,我们在每次清创术中还定量了24种细胞因子和趋化因子。临床上对患者进行了6周的随访,并在明确的伤口闭合后3个月获得了X线照片。在控制已知混杂因素的同时,研究了这些标志物与伤口衰竭或HO之间的关联。结果:存在截肢(p <0.001;优势比[OR],6.1; 95%CI:1.63-27.2),损伤严重度评分(p = 0.002; OR,33.2; 95%CI,4.2-413),伤口表面积(p = 0.001; OR,1.01; 95%CI,1.002-1.009),血清白介素(IL)-3(p = 0.002; OR,2.41; 95%CI,1.5-4.5),血清IL-12p70 (p = 0.01; OR,0.49; 95%CI,0.27-0.81),流出物IL-3(p = 0.02; OR,1.75; 95%CI,1.2-2.9)和流出物IL-13(p = 0.006; OR,0.67; 95%CI,0.50-0.87)与HO的形成独立相关。损伤严重程度评分(p = 0.05; OR,18; 95%CI,5.1-87),伤口表​​面积(p = 0.05; OR,28.7; 95%CI,1.5-1250),血清降钙素([ProCT](p = 0.03; OR,1596; 95%CI,5.1-1,758,613)和流出液IL-6(p = 0.02; OR,83; 95%CI,2.5-5820)与伤口衰竭独立相关。患者的全身和局部炎症反应以及伤口特异性并发症(例如HO和伤口衰竭),但是,未来建立这些数据的模型必须考虑其复杂性,时间依赖性和非线性性质,证据级别:II级,预后研究。有关证据水平的完整说明,请参见《作者说明》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号